Alembic Pharmaceuticals Q3 Results
- BSE: 533573
- NSE: APLLTD
- ISIN: INE901L01018
- Sector: Biotechnology & Drugs
BSE
918.15
10.00 (1.10%)
10.00 (1.10%)Volume5.11 K
Updated: Thu 15 May, 2025 | 15:29:33
NSE
914.556.90 (0.76%)
6.90 (0.76%)Volume80.85 K
Updated: Thu 15 May, 2025 | 15:55:06
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Alembic Pharmaceuticals Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 24 | Sep 24 | QoQ Comp | Dec 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 1,692.74 | 1,647.98 | 2.72% | 1,692.74 | N/A |
| Selling/ General/ Admin Expenses Total | 397.52 | 391.47 | 1.55% | 397.52 | N/A |
| Depreciation/ Amortization | 70.04 | 70.51 | -0.67% | 70.04 | N/A |
| Other Operating Expenses Total | 595.45 | 588.13 | 1.24% | 595.45 | N/A |
| Total Operating Expense | 1,502.55 | 1,466.36 | 2.47% | 1,502.55 | N/A |
| Operating Income | 190.19 | 181.62 | 4.72% | 190.19 | N/A |
| Net Income Before Taxes | 177.78 | 180.42 | -1.46% | 177.78 | N/A |
| Net Income | 138.42 | 153.40 | -9.77% | 138.42 | N/A |
| Diluted Normalized EPS | 7.01 | 7.24 | -3.11% | 7.01 | N/A |